Keyword: Chris Viehbacher CEO

News

Sanofi-Genzyme Investors Eyeing Feb. 15 Deadline

14.02.2011 - Genzyme Corp investors' confidence that the U.S. biotech is close to an agreement to be taken over by Sanofi-Aventis could be shaken if the French drugmaker extends its tender...

News

Sanofi CEO Says Genzyme Offer May Be Extended

10.02.2011 - Sanofi Aventis Chief Executive Chris Viehbacher said in an interview that the French pharmaceuticals group's offer for Genzyme could be extended for a third time, beyond the Feb...

News

Genzyme and Sanofi Boards Meet to Discuss Deal

07.02.2011 - The boards of Sanofi-Aventis SA and Genzyme Corp were scheduled to hold separate meetings on Sunday to discuss a potential deal, but talks may linger into the week, sources...